Using publicly available datasets as detailed above, we identified a statistically significant upregulation in the expression of the NANOG and ALDH1A1 genes in ER+ BC patients compared to ER‐ BC patients (p < 0.001). The gene discussed is NANOG; the disease is breast cancer.